Glaxo splashes out €500m on French vaccine plant
With sales of its vaccines expected to triple in the next ten years, GlaxoSmithKline (GSK) has decided to invest more than €500m in a new manufacturing facility in St-Amand-Les-Eaux in order to increase production capacity for paediatric and adult...